MENU
ERAS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Erasca (ERAS) Earnings Date & Reports

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers... Show more

A.I. Advisor
published Earnings

ERAS is expected to report earnings to rise 6.55% to -11 cents per share on August 07

Erasca ERAS Stock Earnings Reports
Q2'25
Est.
$-0.12
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.06
Q2'24
Missed
by $0.11
The last earnings report on May 13 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 658.60K shares outstanding, the current market capitalization sits at 405.10M.
View a ticker or compare two or three
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ERAS showed earnings on May 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3115 Merryfield Row
Phone
+1 858 465-6511
Employees
126
Web
https://www.erasca.com